Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

3.58B

Market cap3.58B

Price-Earnings ratio

-14.13

Price-Earnings ratio-14.13

Dividend yield

—

Dividend yield—

Average volume

8.17M

Average volume8.17M

High today

$36.72

High today$36.72

Low today

$35.22

Low today$35.22

Open price

$35.69

Open price$35.69

Volume

4.05M

Volume4.05M

52 Week high

$173.25

52 Week high$173.25

52 Week low

$34.10

52 Week low$34.10

SRPT News

TipRanks 20h

Sarepta reports positive ELEVIDYS protein expression data in young patients

Sarepta (SRPT) Therapeutics reported new results from its ENDEAVOR study, also known as Study 9001-103, of ELEVIDYS for Duchenne muscular dystrophy. In cohort 6...

Analyst ratings

81%

of 27 ratings

Buy

81.5%

Hold

18.5%

Sell

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.